SCHEMBL25925862

SCHEMBL25925862

Cn1nccc1/N=N/c1cc(O)c(/N=N/c2ccnn2C)cc1O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.34
ALDH1A1 P00352 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.33
HSP90AA1 P07900 1/20 0.33
CCR6 P51684 1/20 0.33
NPC1 O15118 3/20 0.33
RAB9A P51151 2/20 0.33
AHR P35869 1/20 0.32
KDM4C Q9H3R0 1/20 0.31
KCNH2 Q12809 3/20 0.31
MEN1 O00255 3/20 0.31
KMT2A Q03164 3/20 0.31
KDM4E B2RXH2 2/20 0.31
MAPK1 P28482 2/20 0.31
TDP1 Q9NUW8 2/20 0.31
POLB P06746 1/20 0.31
IDO1 P14902 1/20 0.31
TDO2 P48775 1/20 0.31
GFER P55789 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25925911 0.87 EGFR (0.49) MAPTALDH1A1L3MBTL1NPC1RAB9A
SCHEMBL25925941 0.85 KCNH2 (0.34) KCNH2
SCHEMBL25926077 0.84 TSHR (0.36) MAPTALDH1A1L3MBTL1NPC1RAB9A
SCHEMBL25925864 0.84 L3MBTL1 (0.35) MAPTL3MBTL1HSP90AA1CCR6MEN1
SCHEMBL25925882 0.82 AHR (0.36) MAPTALDH1A1L3MBTL1HSP90AA1NPC1
SCHEMBL25925924 0.82 RAB9A (0.46) MAPTALDH1A1L3MBTL1HSP90AA1NPC1
SCHEMBL25926069 0.82 KCNH2 (0.54) MAPTALDH1A1L3MBTL1NPC1RAB9A
SCHEMBL25925932 0.79 ESR1 (0.33) MAPTALDH1A1HSP90AA1KDM4CMEN1
SCHEMBL25925733 0.79 ALDH1A1 (0.36) MAPTALDH1A1KDM4C
SCHEMBL25925704 0.79 MAPT (0.33) MAPTALDH1A1L3MBTL1HSP90AA1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE FUJIFILM CORPORATION (JP) 2023-08-03 US disclosed
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE FUJIFILM CORPORATION (JP) 2023-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE AR, MAPT, NR5A1 MAPT 2/4885ALDH1A1 580/4885L3MBTL1 3956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.